These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 964523

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Vincapront Retard in geriatrics. Results of a multicenter study on patients with organic psychoses].
    Hinkelmann B, Bentel U, Hangleiter P, Maisenbacher J.
    MMW Munch Med Wochenschr; 1979 Oct 26; 121(43):1427-8. PubMed ID: 119913
    [No Abstract] [Full Text] [Related]

  • 23. [Cerebral circulation and various indices of the functional status of the brain during aging].
    Mints AIa, Litvinenko AA, Bachinskaia NIu.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Oct 26; 85(9):1374-8. PubMed ID: 4072540
    [Abstract] [Full Text] [Related]

  • 24. [Controlled testing of vincamine with special reference to the flow properties of blood].
    Klein M, Szobor A, Bräuer H.
    Med Klin; 1979 Oct 24; Suppl():29-36. PubMed ID: 542163
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [A case of "torsade de pointe" during vincamine therapy].
    Richichi I, Valsecchi O, Falcone C, Sofi A, Zanini L.
    Minerva Cardioangiol; 1978 Mar 24; 26(3):197-200. PubMed ID: 652156
    [No Abstract] [Full Text] [Related]

  • 28. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P, Periti G, Colombo Pirola L.
    Clin Ter; 1981 Apr 30; 97(2):137-45. PubMed ID: 7016415
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M.
    Lille Med; 1978 May 30; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract] [Full Text] [Related]

  • 31. Ethyl apovincaminate therapy in neurovascular diseases.
    Szobor A, Klein M.
    Arzneimittelforschung; 1976 May 30; 26(10a):1984-9. PubMed ID: 1037230
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P, Polák O, Ochsenreither AM.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan 30; 6(1):39-49. PubMed ID: 4602891
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Use of grandaxin in the complex treatment of patients with initial atherosclerotic encephalopathy].
    Mints AIa, Garmash IuIu, Boĭko NR.
    Vrach Delo; 1985 May 30; (5):96-9. PubMed ID: 4013237
    [No Abstract] [Full Text] [Related]

  • 36. [Psychoactive effect of vincamine in a group of subjects affected by recurrent depressive syndrome. Preliminary note].
    Crispi G, Di Lorenzo RS, Gentile A, Florino A, Pannone B, Sciorio G.
    Minerva Med; 1975 Oct 20; 66(70):3683-5. PubMed ID: 1103012
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.